Literature DB >> 26742315

Anti-proliferative effect of the extract of Guangzao (Fructus Choerospondiatis) on cultured rat cardiac fibroblasts.

Lei Jia, Yumin Yang, Deli Zhu, Xiaohui Gao, Xiaoling Wang, Huihui Xing, Junping Bao, Liang Shu.   

Abstract

OBJECTIVE: To ascertain if total flavonoids of Guangzao (Fructus Choerospondiatis) (TFFC) extracted from Guangzao (Fructus Choerospondiatis) can inhibit angiotensin II-induced proliferation of cardiac fibroblasts (CFs).
METHODS: CFs were cultured by the differential attachment method. A model of cell proliferation was established by stimulation with Ang II. Cardiac fibroblasts growth was determined using a hemocytometer. Cell proliferation was detected by methyl thiazole tetrazolium. Lactate dehydrogenase activity was measured by chemical colorimetric method.
RESULTS: Proliferation of TFFC-treated (25, 50, 100 mg/L) fibroblasts was significantly less than that of cells in the angiotensin II group (P < 0.01), and TFFC inhibited proliferation in a dose-dependent manner. These inhibitory effects were partly blocked by pretreatment with NG-nitro-L-arginine methyl ester (L-NAME) and 1H-[1,2,4]-oxadiazole-[4,3-a]-quinoxalin-1-one (ODQ).
CONCLUSION: TFFC inhibited angiotensin II-induced proliferation of cardiac fibroblasts via a mechanism that probably involves activation of the NO-cyclic guanosine monophosphate signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26742315     DOI: 10.1016/s0254-6272(15)30160-6

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  2 in total

1.  Comprehensive Identification of Guan-Xin-Shu-Tong Capsule via a Mass Defect and Fragment Filtering Approach by High Resolution Mass Spectrometry: In Vitro and In Vivo Study.

Authors:  Xun Gao; Jingqing Mu; Qing Li; Shaoyi Guan; Ran Liu; Yiyang Du; Huifen Zhang; Kaishun Bi
Journal:  Molecules       Date:  2017-06-16       Impact factor: 4.411

2.  Validation of efficacy and mechanism of Sanwei-Tanxiang powder in improving myocardial ischemia reperfusion injuries.

Authors:  Yu-Hui Sun; Ren Bu; Yue-Wu Wang; Yu-Chong Hu; Xu-Mei Wang; Xin Dong; Wen Zu; Yan Niu; Peng-Wei Zhao; Peng Sun; Shi-Hang Ru; Jing-Kun Lu; Sheng-Sang Na
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.